{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:58:53Z","timestamp":1791824333533,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100025247","name":"North Dakota Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023027","name":"West Virginia Department of Health and Human Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.japh.2024.102152","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T16:55:02Z","timestamp":1719939302000},"page":"102152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Implementation of a North Dakota opioid misuse and overdose prevention program in West Virginia"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2386-5520","authenticated-orcid":false,"given":"Elizabeth","family":"Skoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Linger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5005-5881","authenticated-orcid":false,"given":"Heidi","family":"Eukel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2575-6501","authenticated-orcid":false,"given":"Susan","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Frenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6900-434X","authenticated-orcid":false,"given":"Jayme","family":"Steig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6040-1103","authenticated-orcid":false,"given":"Mark","family":"Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Werremeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.japh.2024.102152_bib4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.sapharm.2023.05.003","article-title":"A scoping literature review of pharmacy-based opioid misuse screening and brief interventions","volume":"19","author":"Rao","year":"2023","journal-title":"Res Soc Adm Pharm"},{"issue":"2","key":"10.1016\/j.japh.2024.102152_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jac5.1171","article-title":"Pharmacists and the opioid crisis: a narrative review of pharmacists\u2019 practice roles","volume":"3","author":"Bratberg","year":"2020","journal-title":"JACCP J Am Coll Clin Pharm"},{"issue":"1","key":"10.1016\/j.japh.2024.102152_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/07448481.2020.1726931","article-title":"Blue light phones as potential locations for deploying public access naloxone kits on a college campus","volume":"70","author":"Dworkis","year":"2022","journal-title":"J\u00a0Am Coll Health"},{"issue":"8","key":"10.1016\/j.japh.2024.102152_bib7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/jac5.1331","article-title":"Mobilizing pharmacists to address the opioid crisis: a joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy","volume":"3","author":"Coon","year":"2020","journal-title":"JACCP J Am Coll Clin Pharm"},{"issue":"1","key":"10.1016\/j.japh.2024.102152_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.japh.2019.09.003","article-title":"Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose","volume":"60","author":"Skoy","year":"2020","journal-title":"J\u00a0Am Pharm Assoc JAPhA"},{"issue":"4","key":"10.1016\/j.japh.2024.102152_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/08897077.2020.1827126","article-title":"Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose","volume":"42","author":"Skoy","year":"2021","journal-title":"Subst Abuse"},{"key":"10.1016\/j.japh.2024.102152_bib10","author":"Strand"},{"issue":"17","key":"10.1016\/j.japh.2024.102152_bib11","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.3390\/ijerph20176628","article-title":"Implementation of a pharmacy follow-up program for dispensed opioid medications","volume":"20","author":"Skoy","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"10.1016\/j.japh.2024.102152_bib12","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.sapharm.2019.11.016","article-title":"Program evaluation of the opioid and naloxone education (ONE Rx) program using the RE-AIM model","volume":"16","author":"Strand","year":"2020","journal-title":"Res Soc Adm Pharm RSAP"},{"issue":"8","key":"10.1016\/j.japh.2024.102152_bib13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.sapharm.2018.11.006","article-title":"A\u00a0pilot evaluation of incorporating \u201copt-out\u201d naloxone dispensing within a chain community pharmacy","volume":"15","author":"Skoy","year":"2019","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"10.1016\/j.japh.2024.102152_bib14","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.5888\/pcd19.220028","article-title":"Evaluation of a program to screen patients in community pharmacies for opioid misuse and accidental overdose","volume":"19","author":"Skoy","year":"2022","journal-title":"Prev Chronic Dis"},{"issue":"1","key":"10.1016\/j.japh.2024.102152_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/CEH.0000000000000233","article-title":"Changes in pharmacists\u2019 perceptions after a training in opioid misuse and accidental overdose prevention","volume":"39","author":"Eukel","year":"2019","journal-title":"J\u00a0Contin Educ Health Prof"},{"issue":"6","key":"10.1016\/j.japh.2024.102152_bib16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"issue":"8","key":"10.1016\/j.japh.2024.102152_bib17","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.sapharm.2018.07.011","article-title":"Moving opioid misuse prevention upstream: a pilot study of community pharmacists screening for opioid misuse risk","volume":"15","author":"Strand","year":"2023","journal-title":"Res Soc Adm Pharm RSAP"},{"issue":"5","key":"10.1016\/j.japh.2024.102152_bib20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00103-021-03324-x","article-title":"Implementation of evidence-based health promotion and disease prevention interventions: theoretical and practical implications of the concept of transferability for decision-making and the transfer process","volume":"64","author":"Schloemer","year":"2021","journal-title":"Bundesgesundheitsblatt - Gesundheitsforsch - Gesundheitsschutz"},{"issue":"6","key":"10.1016\/j.japh.2024.102152_bib21","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.japh.2022.07.003","article-title":"Access to community pharmacies: a nationwide geographic information systems cross-sectional analysis","volume":"62","author":"Berenbrok","year":"2022","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.japh.2024.102152_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7621","article-title":"Prevention of prescription opioid misuse and projected overdose deaths in the United States","volume":"2","author":"Chen","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.japh.2024.102152_bib25","first-page":"21","article-title":"Pharmacist involvement in combating the opioid crisis: a mixed-methods approach revealing conflicting perceptions","volume":"3","author":"Blue","year":"2020","journal-title":"JACCP"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124001729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124001729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:28:50Z","timestamp":1732040930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124001729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1544319124001729"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102152","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of a North Dakota opioid misuse and overdose prevention program in West Virginia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102152"}}